Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
The instrument operated in data-dependent acquisition mode in positive polarity
Product Overview Product Overview
At concentrations where neither peptide alone is fully effective, the combination kills significantly more bacteria than either individual peptide
ARA-290 (cibinetide) for neuropathy: the clinical trial peptide If BPC-157 represents the strongest preclinical evidence for peptide-based nerve repair, ARA-290 represents the strongest clinical evidence
US$ 22.16
US$ 25.24
US$ 28.88
US$ 25.31
US$ 21.02
US$ 21.12
US$ 29.58
US$ 29.78
